TITLE:
Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer

CONDITION:
Stomach Neoplasms

INTERVENTION:
Treatment group

SUMMARY:

      This study will test whether the G17DT Immunogen, when administered in combination with
      chemotherapy, is an effective and safe treatment for gastric cancer.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion criteria:

          -  Clinical diagnosis with gastric or gastroesophageal cancer

          -  Karnofsky performance status score of at least 70

          -  Life expectancy of at least 3 months

        Exclusion criteria:

          -  Prior treatment with chemotherapy or anticancer immunotherapy

          -  Bone marrow transplant within past year

          -  Chronic use of corticosteroids, except for inhaled corticosteroids used for asthma or
             chronic obstructive pulmonary disease

          -  Central nervous system metastases

          -  Immunodeficiency

          -  Hypercalcemia
      
